Workflow
嘉必优生物技术(武汉)股份有限公司 关于注销部分募集资金专项账户的公告

Fundraising Overview - The company has successfully completed an initial public offering (IPO) of 30,000,000 shares at a price of RMB 23.90 per share, raising a total of RMB 717 million, with a net amount of RMB 648.33 million after deducting issuance costs [1][2] Fund Management and Usage - The company has established a management system for the use and management of the raised funds, ensuring compliance with regulations and protecting investor rights [2] - A tripartite supervision agreement has been signed with the underwriter and the banks to ensure that the funds are used specifically for their intended purposes [2] Account Closure - The company has closed a special account for the raised funds at China Merchants Bank, as the funds in that account have been fully utilized according to regulations [3]